Erratum to Ma et al. Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom. Neurooncol Pract (first published online 27 September 2017 doi:10.1093/nop/npx023)
The authors wish to acknowledge that Heidi Paine (Charing Cross, London) should be listed as one of the collaborators on this paper.